Derisking Psychiatric Drug Development The NIMH's Fast Fail Program, A Novel Precompetitive Model

被引：17
|
作者：
Grabb, Margaret C. [1 ]
Cross, Alan J. [2 ]
Potter, William Z. [1 ]
McCracken, James T. [3 ]
机构：
[1] NIMH, NIH, 6001 Execut Blvd,Room 7203,MSC 9645, Rockville, MD 20852 USA
[2] AstraZeneca Neurosci Innovat Med Unit, Cambridge, MA USA
[3] UCLA Semel Inst Neurosci, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 05期
关键词：
NERVOUS-SYSTEM; AUTISM; PHARMACOLOGY; DISORDERS;
D O I：
10.1097/JCP.0000000000000536
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：419 / 421
页数：3
相关论文
共 50 条
  • [1] The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development
    Krystal, Andrew D.
    Pizzagalli, Diego A.
    Mathew, Sanjay J.
    Sanacora, Gerard
    Keefe, Richard
    Song, Allen
    Calabrese, Joseph
    Goddard, Andrew
    Goodman, Wayne
    Lisanby, Sarah H.
    Smoski, Moria
    Weiner, Richard
    Iosifescu, Dan
    Nurnberger, John
    Szabo, Steven
    Murrough, James
    Shekhar, Anantha
    Potter, William
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (01) : 82 - 84
  • [2] The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development
    Andrew D. Krystal
    Diego A. Pizzagalli
    Sanjay J. Mathew
    Gerard Sanacora
    Richard Keefe
    Allen Song
    Joseph Calabrese
    Andrew Goddard
    Wayne Goodman
    Sarah H. Lisanby
    Moria Smoski
    Richard Weiner
    Dan Iosifescu
    John Nurnberger
    Steven Szabo
    James Murrough
    Anantha Shekhar
    William Potter
    Nature Reviews Drug Discovery, 2019, 18 : 82 - 84
  • [3] Making better early go/no-go decisions in drug development progress in the NIMH FAST-FAIL programme
    Potter, W. Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S150 - S150
  • [4] Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms
    Potter, William Z.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (06) : 523 - 525
  • [5] Derisking and accelerating oral peptide delivery via novel computational drug development tools
    Ford, Leigh
    Jannin, Vincent
    Benameur, Hassan
    Manufacturing Chemist, 2020, 91 (11): : 16 - 19
  • [6] Torching the Haystack: modelling fast-fail strategies in drug development
    Lendrem, Dennis W.
    Lendrem, B. Clare
    DRUG DISCOVERY TODAY, 2013, 18 (7-8) : 331 - 336
  • [7] Something's got to give: psychiatric disease on the rise and novel drug development on the decline
    Chandler, Daniel J.
    DRUG DISCOVERY TODAY, 2013, 18 (3-4) : 202 - 206
  • [8] Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development
    Ekins, Sean
    Williams, Antony J.
    LAB ON A CHIP, 2010, 10 (01) : 13 - 22
  • [9] Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development?
    Brady, Linda
    Davis, Michael
    Pandina, Gahan
    Cannon, Tyrone
    Kolb, Hartmuth
    McPartland, James
    Leptak, Chris
    Horner, Michelle
    Reasner, David
    Lisanby, Sarah
    Graham, Danielle
    Dage, Jeffrey
    Berman, Steven
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 41 - 42
  • [10] Enabling efficient use of digital health technologies to support Parkinson's disease drug development through precompetitive collaboration
    Cedarbaum, J.
    Taylor, K.
    Hill, D.
    Alexander, R.
    Luo, Y.
    Rubens, R.
    Zach, N.
    Cosman, J.
    Dowling, A.
    Fisher, K.
    Oliva, L.
    Hitchcock, J.
    Lawton, M.
    Conrado, D.
    Romero, K.
    Minchik, M.
    Meulien, D.
    Yang, B.
    Forman, M.
    Bataille, L.
    Dexter, D.
    Gallagher, J.
    Braxenthaler, M.
    Lindemann, M.
    Boroojerdi, B.
    Stebbins, G.
    Bloem, B.
    Hu, M.
    Dorsey, E.
    Stephenson, D.
    MOVEMENT DISORDERS, 2019, 34 : S33 - S34
12345